1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cardiometabolic Drug News MAY 2015

Cardiometabolic Drug News MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 17 pages

Industry Trend Analysis - Afrezza Aggressive Pricing Strategy View Playing Out
Industry Brief - BMS/uniQure Collaborate On Cardiovascular Gene Therapy
Industry Brief - Taxus Cardium/Dr Reddy's Sign Deal For Generx
Industry Brief - Merck/Astellas Sign Japanese Co-Commercialisation Deal For Januvia/Suglat Combination Product
Industry Brief - Novo Nordisk Opens Insulin Manufacturing Facility In Russia
Industry Brief - AOP Orphan/Rigi Healthcare Create Rigi Orphan USA To Focus On Rare Diseases
Industry Brief - Cardio3 BioSciences Changes Name To Celyad
Industry Brief - Omeicos Raises Funds To Advance Lead Candidate In Atrial Fibrillation
Industry Brief - Takeda Agrees To Settle Actos Product Liability Lawsuits In US
Industry Brief - InCarda Raises Funds To Advance Inhaled Cardiotherapeutic Programme
Industry Trend Analysis - Patent Challenge Exposes Qsymia's Weaknesses
Industry Brief - Lixiana Approved In Switzerland For NVAF/VTE
Industry Brief - BI Seeks FDA Approval For Additional Pradaxa Indication
Industry Brief - Daiichi Sankyo's Once-Daily Lixiana Receives Positive CHMP Opinion
Industry Brief - Two Additional US Patents Issued For Vivus' Qsymia
Industry Brief - EC Approves Kengrexal/Orbactiv/Raplixa
Industry Brief - Biocon Gains Mexico Insulin Glargine Approval
Industry Brief - FDA Accepts Tresiba/Ryzodeg Resubmissions For Review
Industry Brief - Aurobindo Gains US Sildenafil Approval
Industry Brief - Actavis Initiates Ambrisentan Patent Challenge
Industry Brief - FDA Approves Corlanor For Chronic HF
Industry Brief - FDA Advisory Committee Recommends Approval Of TMC's Cangrelor
Industry Brief - BI's Idarucizumab Gains FDA Priority Review As Reversal Agent For Pradaxa
Industry Brief - Saxenda Available In US
Industry Brief - FDA Approves Expanded Dosing Time For Aggrastat
Industry Brief - RegeneRx Secures US Patent Allowance Covering TB4
Industry Brief - Teva Launches Argatroban Injection In US
Industry Brief - FDA Advisory Committee Recommends Takeda's Alogliptin For Type II Diabetes
Industry Brief - FDA Grants Priority Review To Brilinta For Patients With History Of MI
Industry Brief - FDA Panel To Review Data Supporting Repatha BLA In High Cholesterol Treatment
Industry Brief - FDA Panel Recommends New Saxagliptin CV Safety Information In Type II Diabetes
Industry Brief - AOP Orphan Launches Lojuxta In Australia For HoFH
Industry Brief - Celladon Reports Negative Results For CUPID2 Trial Of Mydicar In Advanced HF
Industry Brief - Portola's Andexanet Alfa Achieves Primary Endpoint For Prolonged Reversal Of Eliquis
Industry Brief - Eisai/Arena Complete Registrational Trials Of Lorcaserin ER Formulation
Industry Brief - Chinese Stem Cell Patent Covering Stempeucel Granted
Industry Brief - Heart Metabolics/FDA Enter SPA Agreement For Perhexiline Phase III HCM Trial
Industry Brief - Resverlogix Granted Chinese Patents Covering RVX-208
Industry Brief - FDA Grants Fast Track Designation To Gencaro
Industry Brief - Reata Receives FDA ODD For Bardoxolone Methyl In PAH
Industry Brief - CymaBay Initiates Phase II Study Of MBX-8025 In HoFH

Table Of Contents

Cardiometabolic Drug News MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.